iShares U.S. Pharmaceuticals ETF: Favorable Long-Term Growth Outlook Should Drive Future Price Appreciation

About: iShares U.S. Pharmaceuticals ETF (IHE), Includes: AGN, BMY, ELAN, JAZZ, JNJ, LLY, MRK, MYL, PFE, ZTS
by: Ploutos Investing
This article is exclusive for subscribers.
Ploutos Investing
Dividend growth investing, growth at reasonable price, value, long-term horizon

Stocks in IHE’s portfolio should benefit from rising global medicine demand.

Most of its top 10 holdings are moaty stocks with competitive position over their peers.

IHE pays a 1.4%-yielding dividend.

ETF Overview

iShares U.S. Pharmaceuticals ETF (IHE) owns a portfolio of large-cap pharmaceutical stocks. The ETF tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. Stocks in IHE's portfolio are